Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.65 HKD | +0.91% | +1.47% | -3.32% |
Apr. 08 | Shanghai INT Medical Instruments Seeks Listing on Chinese Bourse | MT |
Mar. 18 | Shanghai INT Medical Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.32% | 613M | - | ||
+13.32% | 128B | A- | ||
-8.76% | 10.65B | A- | ||
+0.91% | 8.82B | C | ||
+19.02% | 7.19B | C | ||
+21.26% | 4.99B | B+ | ||
+7.63% | 3.4B | C- | ||
+0.05% | 3.03B | B- | ||
-4.80% | 2.14B | - | - | |
-4.72% | 2B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1501 Stock
- Ratings Shanghai INT Medical Instruments Co., Ltd.